Table 3. Use of antidepressant classes as a % of episode duration.
Antidepressant Classes | TRD episodes | Non-TRD episodes (with at leastone ADAP prescription) | P |
Ho: MT = MN; H1: MT<>MN | |||
SSRI | 62% | 70% | a<0.001 |
ATYPICAL AD | 24% | 16% | <0.001 |
SNRI | 25% | 15% | <0.001 |
AD - OTHERS | 24% | 8% | <0.001 |
AP | 7% | 2% | <0.001 |
LITHIUM | 0.4% | 0.0% | <0.001 |
AD – MAOI | 0% | 0% | <0.001 |
Abbreviations: p = p-value, H0 = Null Hypothesis, H1 = Alternative Hypothesis; MT: The proportion of usage of an antidepressant in TRD episodes; MN: The proportion of usage of an antidepressant in non-TRD episodes; ADAP: Antidepressant and antipsychotic/antimanic drugs; SSRI: Selective serotonin reuptake inhibitor; SNRI: Serotonin Norepinephrine reuptake inhibitors; AD: Antidepressant; AP: Antipsychotics; MAOI: Monoamine oxidase inhibitors;
H1: MT<> MN.